Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Mar 06, 2006 by Edgar Snyder

Drugs Trials That Don't Happen

Drugs Trials

Drug makers aren’t keeping their promises, according to the Food and Drug Administration (FDA). Drug trials slated to detect the effectiveness of drugs and if they produce any unwanted side effects are never taking place. Now, the FDA is being criticized for not being tough enough on drug manufacturers that make these promises in order to get their drugs on the market more quickly.

As of September 30, 2005, 797 out of the 1,231 promised drug trials, or 65 percent, had not begun or were pending, according to the FDA. One study even dated back to 1955. Reasons for the delay include high costs and few incentives to actually complete the trials. The FDA could pull the drugs from the market if the trials are not completed in a specified time frame, but they have never actually done this for fear of hurting the patients.

The director of the Office of New Drugs for the FDA stated that only 5 percent of the promised drug trials were delayed. The agency claims the rest of the pending trials are not technically delayed because a timeline for the tests was never determined.

For more information about dangerous or recalled drugs, visit our Dangerous and Recalled Drug Legal Center.

Drug litigation may involve co-counsel.

Source: “New Drugs Hit the Market, but Promised Trials Go Undone.” By Gardiner Harris. New York Times. March 4, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Tweet